Skip to content
Blog
To search this site, enter a search term
Submit
Alzheimer's Disease Genetics Research
About
NIAGADS
Our Projects
Data
Knowledge
Dementia and Alzheimer’s Disease
The Future of Alzheimer’s Disease
Alzheimer’s Disease and You
Human Genetics
Genetics of Alzheimer’s Disease
Findings
Breakthroughs
Publications
Resources
Find Studies
Find Support
FDA approves first AD drug, Cognex (tacrine), which targets memory loss and dementia symptoms
About
About us
Projects
Data
Knowledge
Dementia and Alzheimer’s Disease
The Future of Alzheimer’s Disease
Alzheimer’s Disease and You
Human Genetics
Genetics of Alzheimer’s Disease
Breakthroughs
Publications
Get Involved
Participation Opportunities
Resources
Blog
To search this site, enter a search term
Submit
